首页 > 最新文献

Translational Research最新文献

英文 中文
Angiogenic and reparative potency of a human cardiac CD90− mesenchymal subpopulation in heart ischemic model 人心脏CD90-间充质亚群在心脏缺血模型中的血管生成和修复能力。
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.trsl.2025.08.004
Elisa Gambini , Erica Rurali , Veronica Barbagallo , Sergio Pirola , Alessandro Scopece , Andrea Biondi , Beatrice Bassetti , Manuel Casaburo , Luana Eramo , Giorgio Pio Alberto Marinelli , Diego Farinello , Simona Rodighiero , Yuri D’alessandra , Mattia Chiesa , Gabriella Spaltro , Veronica Ricci , Aoife Gowran , Elisa Castiglioni , Daniele Fileccia , Giuseppe Nanci , Giulio Pompilio

Background

Despite recent significant therapeutic progress, cardiovascular diseases (CVD) remain an unmet clinical, economic, and social burden worldwide. Cell-based therapies have been proposed as therapeutic strategies, however, the overall efficacy was modest.

Objective

We aimed to fully characterize a novel subpopulation of CD90 mesenchymal cells derived from human heart tissue (hCmPC90-) and evaluate its ability to induce cardiac tissue repair and functional recovery.

Methods

We performed a comprehensive phenotypic characterization of the hCmPC90 by flow cytometry and RNA sequencing. A direct comparison of hCmPC90 with previously clinically tested bone marrow- and cardiac-derived cell types, has been conducted both in vitro by means of various assays of angiogenic potency, and in vivo, by testing the ability to ameliorate left ventricular function in a mouse model of acute myocardial infarction (AMI).

Results

hCmPC90 showed distinct surface markers and transcriptional phenotype compared with unselected mesenchymal heart cells (hCmPCs) and the positive CD90 counterpart (hCmPC90+). When human hCmPC90, hCmPC90+, hCmPC, cardiosphere-derived cells (CDCs), and bone marrow-derived CD34+ cells were functionally tested in vitro, hCmPC90 revealed a superior endothelial differentiation ability, higher anti-inflammatory, cardio-protective capacity, and angiocrine activity. Moreover, hCmPC90 showed specific immune-privileged features. When intramyocardially delivered into infarcted mouse hearts, hCmPC90 outperformed three weeks after injection other clinical-grade cell types, as for left ventricular (LV) function and adverse LV remodeling recovery, infarct size reduction, and vascular density augmentation.

Conclusion

hCmPC90 shows a superior biological potency which deserves clinical exploitation as an advanced therapy medicinal product in the context of refractory ischemic heart disease.
背景:尽管近年来心血管疾病的治疗取得了重大进展,但在世界范围内,心血管疾病(CVD)仍然是一个未满足的临床、经济和社会负担。细胞疗法已被提出作为治疗策略,然而,总体疗效一般。目的:我们旨在充分表征来自人类心脏组织的CD90-间充质细胞(hCmPC90-)的新亚群,并评估其诱导心脏组织修复和功能恢复的能力。方法:我们通过流式细胞术和RNA测序对hCmPC90-进行了全面的表型表征。hCmPC90与先前临床测试的骨髓和心脏来源的细胞类型进行了直接比较,在体外通过各种血管生成效力测定,在体内通过测试急性心肌梗死(AMI)小鼠模型中改善左心室功能的能力。结果:与未选择的间充质心脏细胞(hCmPCs)和CD90阳性对应细胞(hCmPC90+)相比,hCmPC90-表现出不同的表面标记和转录表型。在体外对人hCmPC90-、hCmPC90+、hCmPC、心球源性细胞(CDCs)和骨髓源性CD34+细胞进行功能测试时,hCmPC90-显示出优越的内皮分化能力、更高的抗炎、心脏保护能力和血管分泌活性。此外,hCmPC90-表现出特异性免疫特权特征。当心肌内注入梗死小鼠心脏时,hCmPC90-在左室(LV)功能和不良左室重塑恢复、梗死面积缩小和血管密度增加方面的表现优于注射后三周的其他临床级细胞类型。结论:hCmPC90-具有优越的生物学效力,值得作为治疗顽固性缺血性心脏病的先进药物进行临床开发。
{"title":"Angiogenic and reparative potency of a human cardiac CD90− mesenchymal subpopulation in heart ischemic model","authors":"Elisa Gambini ,&nbsp;Erica Rurali ,&nbsp;Veronica Barbagallo ,&nbsp;Sergio Pirola ,&nbsp;Alessandro Scopece ,&nbsp;Andrea Biondi ,&nbsp;Beatrice Bassetti ,&nbsp;Manuel Casaburo ,&nbsp;Luana Eramo ,&nbsp;Giorgio Pio Alberto Marinelli ,&nbsp;Diego Farinello ,&nbsp;Simona Rodighiero ,&nbsp;Yuri D’alessandra ,&nbsp;Mattia Chiesa ,&nbsp;Gabriella Spaltro ,&nbsp;Veronica Ricci ,&nbsp;Aoife Gowran ,&nbsp;Elisa Castiglioni ,&nbsp;Daniele Fileccia ,&nbsp;Giuseppe Nanci ,&nbsp;Giulio Pompilio","doi":"10.1016/j.trsl.2025.08.004","DOIUrl":"10.1016/j.trsl.2025.08.004","url":null,"abstract":"<div><h3>Background</h3><div>Despite recent significant therapeutic progress, cardiovascular diseases (CVD) remain an unmet clinical, economic, and social burden worldwide. Cell-based therapies have been proposed as therapeutic strategies, however, the overall efficacy was modest.</div></div><div><h3>Objective</h3><div>We aimed to fully characterize a novel subpopulation of CD90<sup>−</sup> mesenchymal cells derived from human heart tissue (hCmPC90<sup>-</sup>) and evaluate its ability to induce cardiac tissue repair and functional recovery.</div></div><div><h3>Methods</h3><div>We performed a comprehensive phenotypic characterization of the hCmPC90<sup>−</sup> by flow cytometry and RNA sequencing. A direct comparison of hCmPC90<sup>−</sup> with previously clinically tested bone marrow- and cardiac-derived cell types, has been conducted both <em>in vitro</em> by means of various assays of angiogenic potency, and <em>in vivo,</em> by testing the ability to ameliorate left ventricular function in a mouse model of acute myocardial infarction (AMI).</div></div><div><h3>Results</h3><div>hCmPC90<sup>−</sup> showed distinct surface markers and transcriptional phenotype compared with unselected mesenchymal heart cells (hCmPCs) and the positive CD90 counterpart (hCmPC90<sup>+</sup>). When human hCmPC90<sup>−</sup>, hCmPC90<sup>+</sup>, hCmPC, cardiosphere-derived cells (CDCs), and bone marrow-derived CD34<sup>+</sup> cells were functionally tested <em>in vitro</em>, hCmPC90<sup>−</sup> revealed a superior endothelial differentiation ability, higher anti-inflammatory, cardio-protective capacity, and angiocrine activity. Moreover, hCmPC90<sup>−</sup> showed specific immune-privileged features. When intramyocardially delivered into infarcted mouse hearts, hCmPC90<sup>−</sup> outperformed three weeks after injection other clinical-grade cell types, as for left ventricular (LV) function and adverse LV remodeling recovery, infarct size reduction, and vascular density augmentation.</div></div><div><h3>Conclusion</h3><div>hCmPC90<sup>−</sup> shows a superior biological potency which deserves clinical exploitation as an advanced therapy medicinal product in the context of refractory ischemic heart disease.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 22-35"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appendiceal B lymphocytes contribute to the pathogenesis of experimental colitis through fueling colonic CD4+ T polarization 阑尾B淋巴细胞通过促进结肠CD4+ T极化参与实验性结肠炎的发病机制
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.trsl.2025.09.001
Yu Zhang , Shan Cao , Yun Liu , Ziliang Ke , Zhe Wu , Xiaohui Fang , Yang Zhang , Jingyi Chen , Congyi Yang , Yiken Lin , Ning Chen , Jun Xu , Yulan Liu
The appendix, a component of the gut-associated lymphoid tissue enriched with B lymphocytes, plays a pivotal role in intestinal mucosal immunity. Previous studies have indicated that prior appendectomy may prevent the onset of ulcerative colitis (UC); however, its therapeutic role in UC remains unclear, and prophylactic appendectomy is not a realistic approach to prevent UC. In this study, we confirmed that appendectomy alleviates dextran sodium sulphate (DSS)-induced chronic murine colitis and further demonstrated that appendiceal B (APB) lymphocytes exacerbate colonic inflammation by migrating to the colon via the CCL20–CCR6 axis and facilitating colonic CD4+ T cell-mediated T helper 1 (Th1) and T helper 17 (Th17) immune responses. Single-cell sequencing of colonic tissues revealed IgG+ B cell-skewed responses in patients with UC, and APB cell expansion was positively correlated with disease severity. Immunofluorescence co-staining suggested that colonic B cells of UC patients related to the appendix. These findings highlight the therapeutic potential of appendectomy and B cell-targeted immunotherapy in UC treatment and further introduce the hypothesis that UC with appendiceal orifice inflammation may represent a distinct subtype of the disease.
阑尾是富含B淋巴细胞的肠道相关淋巴组织的组成部分,在肠黏膜免疫中起着关键作用。先前的研究表明,事先阑尾切除术可以预防溃疡性结肠炎(UC)的发生;然而,其在UC中的治疗作用尚不清楚,预防性阑尾切除术并不是预防UC的现实方法。在本研究中,我们证实阑尾切除术减轻了葡糖酐硫酸钠(DSS)诱导的慢性小鼠结肠炎,并进一步证明阑尾B (APB)淋巴细胞通过CCL20-CCR6轴迁移到结肠,促进结肠CD4+ T细胞介导的T辅助1 (Th1)和T辅助17 (Th17)免疫应答,从而加剧结肠炎症。UC患者结肠组织单细胞测序显示IgG+ B细胞偏斜反应,APB细胞扩增与疾病严重程度呈正相关。免疫荧光共染色提示UC患者结肠B细胞与阑尾有关。这些发现强调了阑尾切除术和B细胞靶向免疫疗法在UC治疗中的治疗潜力,并进一步提出了UC伴阑尾口炎症可能代表该疾病不同亚型的假设。
{"title":"Appendiceal B lymphocytes contribute to the pathogenesis of experimental colitis through fueling colonic CD4+ T polarization","authors":"Yu Zhang ,&nbsp;Shan Cao ,&nbsp;Yun Liu ,&nbsp;Ziliang Ke ,&nbsp;Zhe Wu ,&nbsp;Xiaohui Fang ,&nbsp;Yang Zhang ,&nbsp;Jingyi Chen ,&nbsp;Congyi Yang ,&nbsp;Yiken Lin ,&nbsp;Ning Chen ,&nbsp;Jun Xu ,&nbsp;Yulan Liu","doi":"10.1016/j.trsl.2025.09.001","DOIUrl":"10.1016/j.trsl.2025.09.001","url":null,"abstract":"<div><div>The appendix, a component of the gut-associated lymphoid tissue enriched with B lymphocytes, plays a pivotal role in intestinal mucosal immunity. Previous studies have indicated that prior appendectomy may prevent the onset of ulcerative colitis (UC); however, its therapeutic role in UC remains unclear, and prophylactic appendectomy is not a realistic approach to prevent UC. In this study, we confirmed that appendectomy alleviates dextran sodium sulphate (DSS)-induced chronic murine colitis and further demonstrated that appendiceal B (APB) lymphocytes exacerbate colonic inflammation by migrating to the colon via the CCL20–CCR6 axis and facilitating colonic CD4<sup>+</sup> T cell-mediated T helper 1 (Th1) and T helper 17 (Th17) immune responses. Single-cell sequencing of colonic tissues revealed IgG<sup>+</sup> B cell-skewed responses in patients with UC, and APB cell expansion was positively correlated with disease severity. Immunofluorescence co-staining suggested that colonic B cells of UC patients related to the appendix. These findings highlight the therapeutic potential of appendectomy and B cell-targeted immunotherapy in UC treatment and further introduce the hypothesis that UC with appendiceal orifice inflammation may represent a distinct subtype of the disease.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 56-70"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining computational target prioritization and a B cell maturation assay for target evaluation studies in systemic lupus erythematosus 结合计算目标优先级和B细胞成熟测定在系统性红斑狼疮的目标评估研究。
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.trsl.2025.09.002
Ming-Mei Shang , Zhuang Liu , Bogdan Knezevic , Christine Möller Westerberg , Sudeepta Kumar Panda , Hai Fang , Ning Xu Landén , Michael Sundström , Julian C. Knight , Louise Berg

Background and Purpose

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease involving production of autoantibodies by B cells. This study aimed at identifying novel drug targets using a computational algorithm to select targets and thereafter validate the top ranked 11 targets by siRNA knockdown in a primary B cell maturation assay.

Experimental Approach

The top 1 % genes (∼150 genes) from SLE genome-wide association studies were ranked by Priority index (Pi), a computational tool integrating genomic and network information to prioritize disease-relevant genes. These were further filtered by network connectivity, drugability, for ranking highly in autoimmune diseases and for not directly interfering with the B cell stimulation cocktail used. From this, 11 genes were selected for validation by siRNA knockdown: IFNGR1, IL-2, IRF4, IL-12A, IL-12B, VCAM-1, ATF6B, RELA, IKBKG, CHUK and MAPK14. Effects on induced maturation and viability of primary blood B cells were analyzed by flow cytometry, and effects on IgG secretion were investigated by ELISA. RNA-sequencing of B cells treated with siRNA was performed to investigate molecular mechanisms underlying the functional alterations.

Key Results

Experimental results show that several of the targets (IFNGR1, IL-2, IL-12A, MAPK14, IRF4, CHUK, ATF6B, IKBKG, and RELA) are involved in B cell maturation, as knockdown caused reduced IgG production and/or decreased maturation of B cells. The observed variability of effects on IgG secretion and B cell maturation suggests differences in the mechanistic roles of the proteins encoded by these genes. RNA-seq analysis of cells where expression of the targeted genes had been modulated showed effects on the expression level of hundreds of genes involved in cellular processes important for B cell functions.

Conclusion and Implications

Combining the target prioritization algorithm with experimental functional validation studies by gene knockdown and whole transcriptomics profiling constitutes a promising approach to identify potential novel drug targets in immune disorders.
背景和目的:系统性红斑狼疮(SLE)是一种系统性自身免疫性疾病,涉及B细胞产生自身抗体。本研究旨在利用计算算法确定新的药物靶点,然后在原代B细胞成熟实验中通过siRNA敲低验证排名前11位的靶点。实验方法:通过优先指数(Pi)对SLE全基因组关联研究中排名前1%的基因(~ 150个基因)进行排序,Pi是一种整合基因组和网络信息的计算工具,可对疾病相关基因进行优先排序。这些药物通过网络连通性、可药物性、在自身免疫性疾病中的排名以及不直接干扰所使用的B细胞刺激鸡尾酒等因素进一步筛选。从中选择11个基因进行siRNA敲低验证:IFNGR1、IL-2、IRF4、IL-12A、IL-12B、VCAM-1、ATF6B、RELA、IKBKG、CHUK和MAPK14。流式细胞术分析其对原代血B细胞诱导成熟和活力的影响,ELISA法检测其对IgG分泌的影响。用siRNA处理的B细胞进行rna测序,以研究功能改变的分子机制。关键结果:实验结果表明,几个靶点(IFNGR1, IL-2, IL-12A, MAPK14, IRF4, CHUK, ATF6B, IKBKG和RELA)参与B细胞成熟,因为敲低导致IgG产生减少和/或B细胞成熟减慢。观察到的对IgG分泌和B细胞成熟影响的变异性表明,这些基因编码的蛋白质在机制作用上存在差异。对靶基因表达被调节的细胞进行的RNA-seq分析显示,参与对B细胞功能重要的细胞过程的数百个基因的表达水平受到影响。结论与意义:将靶标优先排序算法与基因敲低和全转录组学分析的实验功能验证研究相结合,是一种很有前途的方法,可以识别免疫疾病的潜在新药物靶点。
{"title":"Combining computational target prioritization and a B cell maturation assay for target evaluation studies in systemic lupus erythematosus","authors":"Ming-Mei Shang ,&nbsp;Zhuang Liu ,&nbsp;Bogdan Knezevic ,&nbsp;Christine Möller Westerberg ,&nbsp;Sudeepta Kumar Panda ,&nbsp;Hai Fang ,&nbsp;Ning Xu Landén ,&nbsp;Michael Sundström ,&nbsp;Julian C. Knight ,&nbsp;Louise Berg","doi":"10.1016/j.trsl.2025.09.002","DOIUrl":"10.1016/j.trsl.2025.09.002","url":null,"abstract":"<div><h3>Background and Purpose</h3><div>Systemic lupus erythematosus (SLE) is a systemic autoimmune disease involving production of autoantibodies by B cells. This study aimed at identifying novel drug targets using a computational algorithm to select targets and thereafter validate the top ranked 11 targets by siRNA knockdown in a primary B cell maturation assay.</div></div><div><h3>Experimental Approach</h3><div>The top 1 % genes (∼150 genes) from SLE genome-wide association studies were ranked by Priority index (Pi), a computational tool integrating genomic and network information to prioritize disease-relevant genes. These were further filtered by network connectivity, drugability, for ranking highly in autoimmune diseases and for not directly interfering with the B cell stimulation cocktail used. From this, 11 genes were selected for validation by siRNA knockdown: <em>IFNGR1, IL-2, IRF4, IL-12A, IL-12B, VCAM-1, ATF6B, RELA, IKBKG, CHUK</em> and <em>MAPK14.</em> Effects on induced maturation and viability of primary blood B cells were analyzed by flow cytometry, and effects on IgG secretion were investigated by ELISA. RNA-sequencing of B cells treated with siRNA was performed to investigate molecular mechanisms underlying the functional alterations.</div></div><div><h3>Key Results</h3><div>Experimental results show that several of the targets (<em>IFNGR1, IL-2, IL-12A, MAPK14, IRF4, CHUK, ATF6B, IKBKG,</em> and <em>RELA</em>) are involved in B cell maturation, as knockdown caused reduced IgG production and/or decreased maturation of B cells. The observed variability of effects on IgG secretion and B cell maturation suggests differences in the mechanistic roles of the proteins encoded by these genes. RNA-seq analysis of cells where expression of the targeted genes had been modulated showed effects on the expression level of hundreds of genes involved in cellular processes important for B cell functions.</div></div><div><h3>Conclusion and Implications</h3><div>Combining the target prioritization algorithm with experimental functional validation studies by gene knockdown and whole transcriptomics profiling constitutes a promising approach to identify potential novel drug targets in immune disorders.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 36-46"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145042674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者资讯
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/S1931-5244(25)00098-2
{"title":"Information for Readers","authors":"","doi":"10.1016/S1931-5244(25)00098-2","DOIUrl":"10.1016/S1931-5244(25)00098-2","url":null,"abstract":"","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Page IBC"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delivery of thermogenic genes to metabolic tissues: Effects on body weight and glucose tolerance 产热基因向代谢组织的传递:对体重和葡萄糖耐量的影响。
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.trsl.2025.09.003
Min-Jung Park , Junhyeong Lee , Merc Emil Matienzo , Sangyi Lim , Keon Kim , Chang-Min Lee , Dong-il Kim
Adaptive thermogenesis, particularly via the β3-adrenergic receptor (ADRB3)–protein kinase A catalytic subunit α (PKA Cα)–uncoupling protein 1 (UCP1) pathway, promotes energy expenditure and contributes to metabolic homeostasis, thereby establishing this pathway as a promising therapeutic target for metabolic disorders associated with excessive energy intake. In this study, we aimed to evaluate the therapeutic potential of adeno-associated virus (AAV)-mediated gene therapy targeting thermogenic pathways in metabolic tissues for the treatment of obesity-related dysfunctions. We demonstrated that adipocyte-specific overexpression of UCP1 improved glucose tolerance. Similarly, ADRB3 overexpression significantly enhanced glucose tolerance. Furthermore, ectopic expression of UCP1 in hepatocytes and myofibers also led to improved glucose tolerance. These findings highlight the potential of AAV-mediated gene therapy targeting the ADRB3–PKA Cα–UCP1 axis as a promising strategy for the treatment of obesity-associated metabolic disorders.
适应性产热,特别是通过β3-肾上腺素能受体(ADRB3)-蛋白激酶A催化亚基α (PKA Cα)-解偶联蛋白1 (UCP1)途径,促进能量消耗并有助于代谢稳态,从而将该途径建立为与过度能量摄入相关的代谢紊乱的有希望的治疗靶点。在这项研究中,我们旨在评估腺相关病毒(AAV)介导的靶向代谢组织产热途径的基因治疗治疗肥胖相关功能障碍的潜力。我们证明了脂肪细胞特异性的UCP1过表达改善了葡萄糖耐量。同样,ADRB3过表达显著提高葡萄糖耐量。此外,UCP1在肝细胞和肌纤维中的异位表达也导致葡萄糖耐量的改善。这些发现强调了aav介导的靶向ADRB3-PKA Cα-UCP1轴的基因治疗作为治疗肥胖相关代谢紊乱的有希望的策略的潜力。
{"title":"Delivery of thermogenic genes to metabolic tissues: Effects on body weight and glucose tolerance","authors":"Min-Jung Park ,&nbsp;Junhyeong Lee ,&nbsp;Merc Emil Matienzo ,&nbsp;Sangyi Lim ,&nbsp;Keon Kim ,&nbsp;Chang-Min Lee ,&nbsp;Dong-il Kim","doi":"10.1016/j.trsl.2025.09.003","DOIUrl":"10.1016/j.trsl.2025.09.003","url":null,"abstract":"<div><div>Adaptive thermogenesis, particularly via the β3-adrenergic receptor (ADRB3)–protein kinase A catalytic subunit α (PKA Cα)–uncoupling protein 1 (UCP1) pathway, promotes energy expenditure and contributes to metabolic homeostasis, thereby establishing this pathway as a promising therapeutic target for metabolic disorders associated with excessive energy intake. In this study, we aimed to evaluate the therapeutic potential of adeno-associated virus (AAV)-mediated gene therapy targeting thermogenic pathways in metabolic tissues for the treatment of obesity-related dysfunctions. We demonstrated that adipocyte-specific overexpression of UCP1 improved glucose tolerance. Similarly, ADRB3 overexpression significantly enhanced glucose tolerance. Furthermore, ectopic expression of UCP1 in hepatocytes and myofibers also led to improved glucose tolerance. These findings highlight the potential of AAV-mediated gene therapy targeting the ADRB3–PKA Cα–UCP1 axis as a promising strategy for the treatment of obesity-associated metabolic disorders.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 47-55"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Advisory Board 编辑顾问委员会
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/S1931-5244(25)00096-9
{"title":"Editorial Advisory Board","authors":"","doi":"10.1016/S1931-5244(25)00096-9","DOIUrl":"10.1016/S1931-5244(25)00096-9","url":null,"abstract":"","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Page ii"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Guidelines 作者指导方针
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-09-01 DOI: 10.1016/S1931-5244(25)00097-0
{"title":"Author Guidelines","authors":"","doi":"10.1016/S1931-5244(25)00097-0","DOIUrl":"10.1016/S1931-5244(25)00097-0","url":null,"abstract":"","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages iii-iv"},"PeriodicalIF":5.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer 腹膜灌洗液循环肿瘤细胞及循环肿瘤DNA预测胃癌异时性腹膜转移的有效性
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-08-26 DOI: 10.1016/j.trsl.2025.08.003
Long Bai , Bo Ni , Xiaoyao Shen , Yeqian Zhang , Yujing Guan , Jiayi Gu , Haoyu Zhang , Muerzhate Aimaiti , Shuchang Wang , Ben Yue , Yanying Shen , Zebing Liu , Xiang Xia , Zizhen Zhang

Background

Peritoneal metastasis is a leading cause of death in gastric cancer (GC) patients, highlighting the need for early diagnosis and high-risk population identification. While circulating tumor DNA(ctDNA) and circulating tumor cells (CTC) have been widely studied in blood, their role in peritoneal lavage fluid (PLF) remains unexplored.

Methods

Patients with stage III GC were enrolled, and preoperative/postoperative PLF was collected in this study. ctDNA in PLF supernatant was analyzed via next-generation sequencing (NGS), while CTC in the pellet were detected using Epithelial Cell Adhesion Molecule (EpCAM), Folate Receptor (FR), and Cytokeratin (CK) immunofluorescence.

Results

ctDNA-positive patients had higher peritoneal metastasis risk (preoperative HR: 4.82, 95% CI 1.03–22.54, p = 0.04; postoperative HR: 4.83, 95% CI 1.03–22.54, p = 0.04). CTC-positive patients also showed higher risk (preoperative HR: 6.76, 95% CI 0.92–49.74, p = 0.003; postoperative HR: 7.41, 95% CI 1.67–32.87, p = 0.02). Postoperative ctDNA had higher predictive efficacy for peritoneal metastasis compared to preoperative ctDNA, with AUC values of 0.93 and 0.86. Combined ctDNA/CTC positivity identified the highest recurrence risk (preoperative HR: 8.07, 95% CI 0.96–67.51, p = 0.0012; postoperative HR: 18.14, 95% CI 3.27–100.70, p = 0.0002).

Conclusions

The combination of postoperative ctDNA and CTC in PLF offered the highest accuracy (85%) and risk stratification in predicting peritoneal metastasis (30.30% vs. 66.67%, p = 0.0063). This method may guide the postoperative prophylactic intraperitoneal chemotherapy.
背景腹膜转移是胃癌(GC)患者死亡的主要原因,强调了早期诊断和高危人群识别的必要性。虽然循环肿瘤DNA(ctDNA)和循环肿瘤细胞(CTC)在血液中的作用已被广泛研究,但它们在腹膜灌洗液(PLF)中的作用仍未被探索。方法入选III期GC患者,收集术前/术后PLF。利用下一代测序(NGS)分析PLF上清中的ctDNA,利用上皮细胞粘附分子(EpCAM)、叶酸受体(FR)和细胞角蛋白(CK)免疫荧光检测颗粒中的CTC。结果sctdna阳性患者腹膜转移风险较高(术前HR: 4.82, 95% CI 1.03 ~ 22.54, p = 0.04;术后HR: 4.83, 95% CI 1.03 ~ 22.54, p = 0.04)。ctc阳性患者的风险也较高(术前HR: 6.76, 95% CI 0.92 ~ 49.74, p = 0.003;术后HR: 7.41, 95% CI 1.67 ~ 32.87, p = 0.02)。与术前相比,术后ctDNA对腹膜转移的预测效果更高,AUC值分别为0.93和0.86。ctDNA/CTC联合阳性提示复发风险最高(术前HR: 8.07, 95% CI 0.96 ~ 67.51, p = 0.0012;术后HR: 18.14, 95% CI 3.27 ~ 100.70, p = 0.0002)。结论术后联合ctDNA和CTC预测PLF腹膜转移的准确率最高(85%),风险分层最高(30.30% vs 66.67%, p = 0.0063)。该方法可指导术后预防性腹腔内化疗。
{"title":"Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer","authors":"Long Bai ,&nbsp;Bo Ni ,&nbsp;Xiaoyao Shen ,&nbsp;Yeqian Zhang ,&nbsp;Yujing Guan ,&nbsp;Jiayi Gu ,&nbsp;Haoyu Zhang ,&nbsp;Muerzhate Aimaiti ,&nbsp;Shuchang Wang ,&nbsp;Ben Yue ,&nbsp;Yanying Shen ,&nbsp;Zebing Liu ,&nbsp;Xiang Xia ,&nbsp;Zizhen Zhang","doi":"10.1016/j.trsl.2025.08.003","DOIUrl":"10.1016/j.trsl.2025.08.003","url":null,"abstract":"<div><h3>Background</h3><div>Peritoneal metastasis is a leading cause of death in gastric cancer (GC) patients, highlighting the need for early diagnosis and high-risk population identification. While circulating tumor DNA(ctDNA) and circulating tumor cells (CTC) have been widely studied in blood, their role in peritoneal lavage fluid (PLF) remains unexplored.</div></div><div><h3>Methods</h3><div>Patients with stage III GC were enrolled, and preoperative/postoperative PLF was collected in this study. ctDNA in PLF supernatant was analyzed via next-generation sequencing (NGS), while CTC in the pellet were detected using Epithelial Cell Adhesion Molecule (EpCAM), Folate Receptor (FR), and Cytokeratin (CK) immunofluorescence.</div></div><div><h3>Results</h3><div>ctDNA-positive patients had higher peritoneal metastasis risk (preoperative HR: 4.82, 95% CI 1.03–22.54, p = 0.04; postoperative HR: 4.83, 95% CI 1.03–22.54, p = 0.04). CTC-positive patients also showed higher risk (preoperative HR: 6.76, 95% CI 0.92–49.74, p = 0.003; postoperative HR: 7.41, 95% CI 1.67–32.87, p = 0.02). Postoperative ctDNA had higher predictive efficacy for peritoneal metastasis compared to preoperative ctDNA, with AUC values of 0.93 and 0.86. Combined ctDNA/CTC positivity identified the highest recurrence risk (preoperative HR: 8.07, 95% CI 0.96–67.51, p = 0.0012; postoperative HR: 18.14, 95% CI 3.27–100.70, p = 0.0002).</div></div><div><h3>Conclusions</h3><div>The combination of postoperative ctDNA and CTC in PLF offered the highest accuracy (85%) and risk stratification in predicting peritoneal metastasis (30.30% vs. 66.67%, p = 0.0063). This method may guide the postoperative prophylactic intraperitoneal chemotherapy.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 13-21"},"PeriodicalIF":5.9,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging 通过磁颗粒成像无创跟踪胃癌中spions标记的cldn18.2靶向CAR-T细胞
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-08-13 DOI: 10.1016/j.trsl.2025.08.002
Meng He , Lijie Ge , Hui Hui , Yali Zhou , Yingxiu Tang , Lin Shen , Jie Tian , Bo Wu , Changsong Qi , Yang Du , Lei Tang
This study aims to employ magnetic particle imaging (MPI) for in vivo tracking and quantitative assessment of targeting capability of CLDN18.2-specific CAR-T cells. CLDN18.2-targeted CAR-T cells were labeled with superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic particle imaging (MPI), and with the near-infrared fluorescent dye DiR for fluorescence molecular imaging (FMI) before infusion. SPIONs-labeled and unlabeled CAR-T cells were administered intravenously to NOD/SCID mice bearing HGC27 xenograft tumors, either independently or in combination with anti-PD-L1 (aPD-L1) antibody (n = 3 for imaging and n = 5 for treatment). The FMI and MPI successfully monitored the dynamic migration and tumor targeting of CAR-T cells towards CLDN18.2-overexpressing tumors. On the fifth day post-infusion, the MPI signal of SPIONs-labeled CAR-T cells was significantly higher in the tumor than that of labeled normal T cells. MPI combined with FMI successfully monitored the targeting of CLDN18.2-specific CAR-T cells in gastric cancer, providing a potential framework for evaluating CAR-T therapy combined with aPD-L1 immunotherapy.
本研究旨在利用磁颗粒成像(MPI)技术对cldn18.2特异性CAR-T细胞的体内靶向能力进行跟踪和定量评估。cldn18.2靶向CAR-T细胞在输注前用超顺磁性氧化铁纳米颗粒(SPIONs)标记进行磁颗粒成像(MPI),用近红外荧光染料DiR标记进行荧光分子成像(FMI)。将spons标记和未标记的CAR-T细胞静脉注射给携带HGC27异种移植肿瘤的NOD/SCID小鼠,单独或联合抗pd - l1 (aPD-L1)抗体(n = 3用于成像,n = 5用于治疗)。FMI和MPI成功地监测了CAR-T细胞对过表达cldn18.2的肿瘤的动态迁移和肿瘤靶向。注射后第5天,spions标记的CAR-T细胞在肿瘤中的MPI信号明显高于标记的正常T细胞。MPI联合FMI成功地监测了cldn18.2特异性CAR-T细胞在胃癌中的靶向性,可能指导CAR-T联合aPD-L1免疫治疗的评估。
{"title":"Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging","authors":"Meng He ,&nbsp;Lijie Ge ,&nbsp;Hui Hui ,&nbsp;Yali Zhou ,&nbsp;Yingxiu Tang ,&nbsp;Lin Shen ,&nbsp;Jie Tian ,&nbsp;Bo Wu ,&nbsp;Changsong Qi ,&nbsp;Yang Du ,&nbsp;Lei Tang","doi":"10.1016/j.trsl.2025.08.002","DOIUrl":"10.1016/j.trsl.2025.08.002","url":null,"abstract":"<div><div>This study aims to employ magnetic particle imaging (MPI) for in vivo tracking and quantitative assessment of targeting capability of CLDN18.2-specific CAR-T cells. CLDN18.2-targeted CAR-T cells were labeled with superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic particle imaging (MPI), and with the near-infrared fluorescent dye DiR for fluorescence molecular imaging (FMI) before infusion. SPIONs-labeled and unlabeled CAR-T cells were administered intravenously to NOD/SCID mice bearing HGC27 xenograft tumors, either independently or in combination with anti-PD-L1 (aPD-L1) antibody (n = 3 for imaging and n = 5 for treatment). The FMI and MPI successfully monitored the dynamic migration and tumor targeting of CAR-T cells towards CLDN18.2-overexpressing tumors. On the fifth day post-infusion, the MPI signal of SPIONs-labeled CAR-T cells was significantly higher in the tumor than that of labeled normal T cells. MPI combined with FMI successfully monitored the targeting of CLDN18.2-specific CAR-T cells in gastric cancer, providing a potential framework for evaluating CAR-T therapy combined with aPD-L1 immunotherapy.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"283 ","pages":"Pages 3-12"},"PeriodicalIF":5.9,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者资讯
IF 5.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-08-01 DOI: 10.1016/S1931-5244(25)00084-2
{"title":"Information for Readers","authors":"","doi":"10.1016/S1931-5244(25)00084-2","DOIUrl":"10.1016/S1931-5244(25)00084-2","url":null,"abstract":"","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"282 ","pages":"Page IBC"},"PeriodicalIF":5.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144810635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Translational Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1